Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FIBROGEN INC Director's Dealing 2016

Dec 3, 2016

34576_dirs_2016-12-02_2d3a2f64-7d59-4217-a5cc-a0859fe2e9f7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2016-12-01

Reporting Person: Neff Thomas B (Director, Chief Executive Officer, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-12-01 Common Stock F 4689 $20.55 Disposed 3303243 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 145070 Indirect
Common Stock 20000 Indirect
Common Stock 60946 Indirect

Footnotes

F1: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.

F2: The shares are held by BioGrowth Partners, LP. The reporting person is the sole general partner of BioGrowth Partners, LP and has sole voting and dispositive power over the shares held by BioGrowth Partners, LP.